Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Molimard

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
La Revue Du Praticien|March 25, 2026
Hervé Maisonneuve, Dominique Costagliola, Mathieu Molimard
Medecine Sciences : M/S|May 29, 2026
[Accurate health information: A requirement for safety and social cohesion]Dominique Costagliola, Hervé Maisonneuve, Mathieu Molimard
Therapie|August 13, 2009
Value of post-registration studies for reimbursement renewalMathieu Molimard, Marion Bamberger, Muriel Vray
Expert Review of Respiratory Medicine|March 6, 2020
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?Philippe Devillier, Pascal Demoly, Mathieu Molimard
Therapie|September 13, 2022
Benefit-risk balance of COVID drugs. New prospectsJean-Luc Cracowski, Vincent Richard, Mathieu Molimard
Therapie|June 20, 2020
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemicJean-Luc Cracowski, Mathieu Molimard, Vincent Richard
Therapie|June 13, 2021
COVID-19: Pharmacology has kept the science ship running during the stormMathieu Molimard, Vincent Richard, Jean-Luc Cracowski
Drug Metabolism Reviews|July 16, 2009
Gender and interindividual variability in pharmacokineticsJean-Marie Nicolas, Pascal Espie, Mathieu Molimard
The New England Journal of Medicine|December 30, 2016
Effectiveness of Fluticasone Furoate-Vilanterol in COPDPierre-Olivier Girodet, Chantal Raherison, Mathieu Molimard
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary diseaseMathieu Molimard, Pierre Oliver Girodet, Nicholas Moore
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
La Revue Du Praticien|March 25, 2026
Hervé Maisonneuve, Dominique Costagliola, Mathieu Molimard
Medecine Sciences : M/S|May 29, 2026
[Accurate health information: A requirement for safety and social cohesion]Dominique Costagliola, Hervé Maisonneuve, Mathieu Molimard
Therapie|August 13, 2009
Value of post-registration studies for reimbursement renewalMathieu Molimard, Marion Bamberger, Muriel Vray
Expert Review of Respiratory Medicine|March 6, 2020
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?Philippe Devillier, Pascal Demoly, Mathieu Molimard
Therapie|September 13, 2022
Benefit-risk balance of COVID drugs. New prospectsJean-Luc Cracowski, Vincent Richard, Mathieu Molimard
Therapie|June 20, 2020
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemicJean-Luc Cracowski, Mathieu Molimard, Vincent Richard
Therapie|June 13, 2021
COVID-19: Pharmacology has kept the science ship running during the stormMathieu Molimard, Vincent Richard, Jean-Luc Cracowski
Drug Metabolism Reviews|July 16, 2009
Gender and interindividual variability in pharmacokineticsJean-Marie Nicolas, Pascal Espie, Mathieu Molimard
The New England Journal of Medicine|December 30, 2016
Effectiveness of Fluticasone Furoate-Vilanterol in COPDPierre-Olivier Girodet, Chantal Raherison, Mathieu Molimard
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary diseaseMathieu Molimard, Pierre Oliver Girodet, Nicholas Moore
Pageof 17